Q&A: Management of Moderate to Severe Atopic Dermatitis in Infants and Young Children
  • CME
  • CE

Expert faculty answer questions about distinguishing food allergies and atopic dermatitis and the treatment of moderate to severe atopic dermatitis in infants and young children.
Robert Sidbury, MD, MPH
Jonathan Silverberg, MD, PhD, MPH
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Physician Assistants: 0.25 AAPA Category 1 CME Credit
Released: January 24, 2023 Expiration: January 23, 2024

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Review efficacy and safety data for infants and young children, tweens and teens, and adults with moderate to severe AD.
  • Select optimal therapy for patients with moderate to severe AD based on indication and efficacy and safety data.

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Children's Hospital
University of Washington School of Medicine
Seattle, Washington

Robert Sidbury, MD, MPH:consultant/advisor/speaker: Beiersdorf, Leo, Lilly, Micreos; researcher: Castle, Galderma, Pfizer, Regeneron, UCB.
Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing

George Washington University School of Medicine and Health Sciences
Washington, DC

Jonathan Silverberg, MD, PhD, MPH:consultant/advisor: AbbVie, Aobiome, Amgen, Arcutis, Arena, Asana, Aslan, BioMX, Biosion, Bodewell, Boehringer Ingelheim, Cara, Castle Biosciences, Celgene, Connect Biopharma, Dermavant, Dermira, Dermtech, Galderma, GlaxoSmithKline, Incyte, Kiniksa, Leo, Lilly, Menlo, Novartis, Optum, Pfizer, RAPT, Regeneron, Sanofi, Shaperon, Union.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Kristine Kucera, PA-C, MPAS, DHSc and Victoria Garcia-Albea, NP, DCNP, as noted below:

Kristine Kucera, PA-C, MPAS, DHSc: consultant/advisor/speaker: AbbVie, Amgen, Beiersdorf, Bristol-Myers Squibb, Dermavant, Leo, Novartis, Sun, UCB.

Victoria Garcia-Albea, NP, DCNP: consultant/advisor/speaker: Sanofi-Genzyme.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This education is intended for dermatologists, allergists, nurse practitioners, physician associates/physician assistants, nurses, and other healthcare professionals who treat pediatric and adult patients with moderate to severe atopic dermatitis.

Goal

The goal of this educational program is to improve learners’ knowledge and competence regarding improving the management of pediatric and adult patients with moderate to severe atopic dermatitis.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until January 23, 2024. PAs should only claim commensurate with the extent of their participation.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 24, 2023, through January 23, 2024:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Acknowledgements

Supported by an educational grant from
Sanofi Genzyme

Related Content

Quick reference guide on the basic and nonpharmacologic management of moderate to severe atopic dermatitis, from Clinical Care Options (CCO)

Released: January 26, 2023

Get the latest evidence-based updates the latest in the management of moderate to severe for adults from Clinical Care Options (CCO)

Robert Sidbury, MD, MPH Jonathan Silverberg, MD, PhD, MPH Released: January 13, 2023

On-demand, case-based video module with dermatology experts reviewing the latest in the management of moderate to severe for tweens and teens from Clinical Care Options (CCO).

Robert Sidbury, MD, MPH Jonathan Silverberg, MD, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Physician Assistants: 0.25 AAPA Category 1 CME credits Released: January 13, 2023 Expired: January 12, 2024

Get the latest evidence-based updates on the management of moderate to severe for tweens and teens from Clinical Care Options (CCO).

Robert Sidbury, MD, MPH Jonathan Silverberg, MD, PhD, MPH Released: January 13, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings